Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143637
Status:
COMPLETED
Last Update Posted:
2008-03-27
First Post:
2005-09-01
Brief Title:
Dose Response Relations for Health Effects Caused by Office Dust
Sponsor:
University of Aarhus
Organization:
University of Aarhus
Study Overview
Official Title:
Dose Response Relations for Health Effects Caused by Office Dust
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is focused at the dose response relation for office dust and such office dust spiked with components from fungi known from damp buildings
The first aim of this study is to investigate if dust causes objective changes such as changes of lung function nasal geometry inflammatory indicators in tears and nasal lavage tear film stability and cells at exposure levels relevant to indoor air The controlled exposure variable is air concentration of office dust spiked with Glucan to simulate a worse case scenario
Aim 1 Confirm or support the causality between objective effects and exposures to dust spiked with Glucan with focus on inflammatory responses This is done by negation of the hypothesis that no significant effects are found for the variables in question
Aim 2 is to estimate the thresholds and slopes of the DR relation for effect measures which show effects of exposures At best the study will supply for each variable a zero response to clean air and three non-zero responses to dust Thresholds and slopes are estimated graphically by linear regression or by an accumulated response model
Aim 3 is a confirmation that atopic persons and histamine sensitive persons in nasal provocation tests have different responses in the effect measures showing significant effects of exposures to dust spiked with Glucan Risk group status is therefore included in the analyses of the main variables as explaining variable
Potential additional aim 4 Chemical and biological characterization of the office dust used in the study
Aim 4 is an investigation of dose response relations for explorative measures which in previous investigations have showed indications of a dose response relation For these no a priory hypotheses exists and the analyses must be arranged ad hoc The explaining variables are exposure and risk group status
One challenge in investigations of unspecific effects caused by mixed exposures is that few specific objective effects measures are available and subjective measures have to be introduced Therefore there is a need for developments of new objective measures of health effects of air pollution Some of these are related to new biomarkers of respiratory effects in a bio-sample taken as condensed exhaled breath
Aim 5 Developments of new objective measures of health effects of air pollution After the experiment it will be investigated by logistic regression if a sensitivity index can be established
The first aim of this study is to investigate if dust causes objective changes such as changes of lung function nasal geometry inflammatory indicators in tears and nasal lavage tear film stability and cells at exposure levels relevant to indoor air The controlled exposure variable is air concentration of office dust spiked with Glucan to simulate a worse case scenario
Aim 1 Confirm or support the causality between objective effects and exposures to dust spiked with Glucan with focus on inflammatory responses This is done by negation of the hypothesis that no significant effects are found for the variables in question
Aim 2 is to estimate the thresholds and slopes of the DR relation for effect measures which show effects of exposures At best the study will supply for each variable a zero response to clean air and three non-zero responses to dust Thresholds and slopes are estimated graphically by linear regression or by an accumulated response model
Aim 3 is a confirmation that atopic persons and histamine sensitive persons in nasal provocation tests have different responses in the effect measures showing significant effects of exposures to dust spiked with Glucan Risk group status is therefore included in the analyses of the main variables as explaining variable
Potential additional aim 4 Chemical and biological characterization of the office dust used in the study
Aim 4 is an investigation of dose response relations for explorative measures which in previous investigations have showed indications of a dose response relation For these no a priory hypotheses exists and the analyses must be arranged ad hoc The explaining variables are exposure and risk group status
One challenge in investigations of unspecific effects caused by mixed exposures is that few specific objective effects measures are available and subjective measures have to be introduced Therefore there is a need for developments of new objective measures of health effects of air pollution Some of these are related to new biomarkers of respiratory effects in a bio-sample taken as condensed exhaled breath
Aim 5 Developments of new objective measures of health effects of air pollution After the experiment it will be investigated by logistic regression if a sensitivity index can be established
Detailed Description:
The basic procedure is an exposure experiment in which human subjects are exposed to controlled variations of dust spiked with Glucan Their responses are monitored before after minutes and hours of exposure and later the same evening
Two groups of subjects are selected in a pre-investigation using strict selection and exclusion criteria The two groups are atopic persons and responders to Histamine in a RSM nasal provocation test
The groups are exposed under controlled conditions in a climate chamber at IMA to office dust spiked with Glucan same procedure and amount as in DAMOS at clean air level less than 20 micro-gm3 TSP and at 150 300 and 700 micro-gm3 TSP In the pre-investigation and during the exposure sessions a number of personal characteristics are measured or registered to be used in the statistical analyses as explaining variables for the responses of the subjects
The dust exposure will be characterized both though its size distribution and gravimetrically using up-to-date analytical instruments To optimise the exposures several pilot studies are made Only effects measures which previously have shown clear indications of responses to dust exposures are included in the study
The timetable includes pre-investigations two repetitions of the exposure design run 1 and 2 analyses of the bio-samples statistical analyses and reporting
The study includes a main study and several additional work-packages which will be activated when funding become available
Two groups of subjects are selected in a pre-investigation using strict selection and exclusion criteria The two groups are atopic persons and responders to Histamine in a RSM nasal provocation test
The groups are exposed under controlled conditions in a climate chamber at IMA to office dust spiked with Glucan same procedure and amount as in DAMOS at clean air level less than 20 micro-gm3 TSP and at 150 300 and 700 micro-gm3 TSP In the pre-investigation and during the exposure sessions a number of personal characteristics are measured or registered to be used in the statistical analyses as explaining variables for the responses of the subjects
The dust exposure will be characterized both though its size distribution and gravimetrically using up-to-date analytical instruments To optimise the exposures several pilot studies are made Only effects measures which previously have shown clear indications of responses to dust exposures are included in the study
The timetable includes pre-investigations two repetitions of the exposure design run 1 and 2 analyses of the bio-samples statistical analyses and reporting
The study includes a main study and several additional work-packages which will be activated when funding become available
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DORES2002 | None | None | None |